OBJECTIVES/HYPOTHESIS: Epidermal growth factor receptor (EGFR) and p16 (a surrogate marker of human papillomavirus [HPV] infection) expression are strong prognostic factors in patients with head and neck squamous cell carcinoma (HNSCC). STUDY DESIGN: We examined expression levels of total and nuclear EGFR as well as p16 status based on evidence that nuclear EGFR may have a role in DNA damage repair. METHODS: An HPV-negative (SQ20B) and an HPV-positive (UMSCC47) HNSCC cell line were examined for EGFR and γH2AX expression. A tissue microarray containing 123 cores obtained from 101 HNSCC tumors was analyzed for EGFR expression by automated quantitative analysis and p16 expression by immunohistochemical staining, and these results were correlated with available clinical data. RESULTS: SQ20B had higher EGFR expression than UMSCC47. Nuclear localization of EGFR on activation with transforming growth factor-α was observed in SQ20B, but not in UMSCC47. SQ20B also had increased γH2AX foci compared to UMSCC47, suggesting that SQ20B has more DNA damage compared to UMSCC47. Total and nuclear EGFR was reliably obtained from 80 of 101 patients. p16 levels were determined in 87 of 101 patients. p16 levels were strongly associated with the oropharyngeal subsite and poorly differentiated histology. Expression of total and nuclear EGFR was higher in p16-negative tumors compared to p16-positive tumors (Wilcoxon rank test, P = .038 and P = .014, respectively). CONCLUSIONS: Further studies are required to determine a mechanistic link between these two prognostic factors and the significance of EGFR localization to nucleus in DNA damage repair pathway activation.
OBJECTIVES/HYPOTHESIS: Epidermal growth factor receptor (EGFR) and p16 (a surrogate marker of humanpapillomavirus [HPV] infection) expression are strong prognostic factors in patients with head and neck squamous cell carcinoma (HNSCC). STUDY DESIGN: We examined expression levels of total and nuclear EGFR as well as p16 status based on evidence that nuclear EGFR may have a role in DNA damage repair. METHODS: An HPV-negative (SQ20B) and an HPV-positive (UMSCC47) HNSCC cell line were examined for EGFR and γH2AX expression. A tissue microarray containing 123 cores obtained from 101 HNSCC tumors was analyzed for EGFR expression by automated quantitative analysis and p16 expression by immunohistochemical staining, and these results were correlated with available clinical data. RESULTS: SQ20B had higher EGFR expression than UMSCC47. Nuclear localization of EGFR on activation with transforming growth factor-α was observed in SQ20B, but not in UMSCC47. SQ20B also had increased γH2AX foci compared to UMSCC47, suggesting that SQ20B has more DNA damage compared to UMSCC47. Total and nuclear EGFR was reliably obtained from 80 of 101 patients. p16 levels were determined in 87 of 101 patients. p16 levels were strongly associated with the oropharyngeal subsite and poorly differentiated histology. Expression of total and nuclear EGFR was higher in p16-negative tumors compared to p16-positive tumors (Wilcoxon rank test, P = .038 and P = .014, respectively). CONCLUSIONS: Further studies are required to determine a mechanistic link between these two prognostic factors and the significance of EGFR localization to nucleus in DNA damage repair pathway activation.
Authors: Amanda Psyrri; Ziwei Yu; Paul M Weinberger; Clarence Sasaki; Bruce Haffty; Robert Camp; David Rimm; Barbara Ann Burtness Journal: Clin Cancer Res Date: 2005-08-15 Impact factor: 12.531
Authors: Klaus Dittmann; Claus Mayer; Birgit Fehrenbacher; Martin Schaller; Uma Raju; Luka Milas; David J Chen; Rainer Kehlbach; H Peter Rodemann Journal: J Biol Chem Date: 2005-07-05 Impact factor: 5.157
Authors: Khurram Khan; Koji Araki; Daiyou Wang; Guayan Li; Xin Li; Jie Zhang; Weizheng Xu; Randall K Hoover; Susan Lauter; Bert O'Malley; Rena G Lapidus; Daqing Li Journal: Head Neck Date: 2010-03 Impact factor: 3.147
Authors: Lanea M Keller; Thomas J Galloway; Thomas Holdbrook; Karen Ruth; Donghua Yang; Cara Dubyk; Douglas Flieder; Miriam N Lango; Ranee Mehra; Barbara Burtness; John A Ridge Journal: Head Neck Date: 2014-01-13 Impact factor: 3.147
Authors: Guoqing Qian; Ning Jiang; Dongsheng Wang; Scott Newman; Sungjin Kim; Zhengjia Chen; Gabriela Garcia; Gavin MacBeath; Dong M Shin; Fadlo R Khuri; Zhuo G Chen; Nabil F Saba Journal: Cancer Date: 2015-07-20 Impact factor: 6.860
Authors: Andrew M Tilston-Lünel; Kathryn E Haley; Nicolas F Schlecht; Yanhua Wang; Abigail L D Chatterton; Susana Moleirinho; Ailsa Watson; Harinder S Hundal; Michael B Prystowsky; Frank J Gunn-Moore; Paul A Reynolds Journal: J Mol Cell Biol Date: 2016-10-01 Impact factor: 6.216
Authors: Stuart E Samuels; Avraham Eisbruch; Jonathan J Beitler; June Corry; Carol R Bradford; Nabil F Saba; Michiel W M van den Brekel; Robert Smee; Primož Strojan; Carlos Suárez; William M Mendenhall; Robert P Takes; Juan P Rodrigo; Missak Haigentz; Alexander D Rapidis; Alessandra Rinaldo; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2015-10-13 Impact factor: 3.236